Showing results (11-20 of 2,058) with videos related to
Sort By:
Pageof 206
Prostaglandins, Leukotrienes, and Medicine|August 1, 1982
Effects of smoking on platelets and on plasma thromboxane-prostacyclin balance in manP Mehta, J MehtaThrombosis Research|January 1, 1982
Potentiation of endoperoxide analog-induced platelet aggregation by heparinP Mehta, J MehtaThe American Journal of Cardiology|February 1, 1983
Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalolL Roy, J Mehta, P MehtaThe Journal of Laboratory and Clinical Medicine|December 1, 1985
Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable anginaJ Mehta, P Mehta, N OstrowskiThe American Journal of the Medical Sciences|January 1, 1986
Calcium blocker diltiazem inhibits platelet activation and stimulates vascular prostacyclin synthesisJ Mehta, P Mehta, N OstrowskiClinical Pharmacology and Therapeutics|November 1, 1983
Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generationJ Mehta, P Mehta, N OstrowskiThe Journal of Laboratory and Clinical Medicine|July 1, 1983
Effects of nitroglycerin on human vascular prostacyclin and thromboxane A2 generationJ Mehta, P Mehta, N OstrowskiAmerican Heart Journal|May 1, 1985
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery diseaseL Roy, J Mehta, P MehtaProstaglandins, Leukotrienes, and Medicine|November 1, 1983
Effect of different amounts of arachidonic acid on vessel wall-generated PGI2 and TXA2J Mehta, P Mehta, N OstrowskiProstaglandins, Leukotrienes, and Medicine|September 1, 1983
Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581J Mehta, P Mehta, N OstrowskiPageof 206